Forbes July 7, 2020
As Covid-19 continues to threaten lives and livelihoods around the world, a great emphasis has been put on preventing and treating the disease. However, putting a human drug through the FDA approval process costs hundreds of millions of dollars and takes months, if not years, of clinical trials. What if one of the over 7,800 human drugs already approved by the FDA could treat Covid-19? That is the hope of hundreds of researchers around the world.
Our global health situation places a spotlight on this significant trend in artificial intelligence—AI drug discovery. In this year’s AI 50 List of America’s Most Promising Artificial Intelligence Companies, several AI drug discovery companies are recognized, including Atomwise, Genesis Therapeutics, Recursion Pharmaceuticals and twoXAR....
Today's Sponsors
Today's Sponsor